PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.07%
Negative revenue growth while AR stands at 4.64%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.51%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-37.21%
Negative EBIT growth while AR is at 94.90%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.21%
Negative operating income growth while AR is at 94.90%. Joel Greenblatt would press for urgent turnaround measures.
133.62%
Net income growth above 1.5x AR's 55.38%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
131.25%
EPS growth above 1.5x AR's 55.56%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
131.25%
Diluted EPS growth above 1.5x AR's 55.56%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.96%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-18.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-52.08%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.47%
Negative 10Y revenue/share CAGR while AR stands at 857.21%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.22%
Negative 5Y CAGR while AR stands at 857.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-20.55%
Negative 3Y CAGR while AR stands at 857.21%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
19.51%
10Y OCF/share CAGR under 50% of AR's 267.52%. Michael Burry would worry about a persistent underperformance in cash creation.
-60.24%
Negative 5Y OCF/share CAGR while AR is at 267.52%. Joel Greenblatt would question the firm’s operational model or cost structure.
-20.86%
Negative 3Y OCF/share CAGR while AR stands at 267.52%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
34.57%
Below 50% of AR's 91.21%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
14.92%
Below 50% of AR's 91.21%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
53.00%
3Y net income/share CAGR 50-75% of AR's 91.21%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
-25.90%
Negative equity/share CAGR over 10 years while AR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.54%
Negative 5Y equity/share growth while AR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-60.18%
Negative 3Y equity/share growth while AR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
34.87%
Dividend/share CAGR of 34.87% while AR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-83.16%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-66.20%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-3.69%
Firm’s AR is declining while AR shows 7.61%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.28%
Inventory is declining while AR stands at 34.13%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.90%
Asset growth at 50-75% of AR's 12.77%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
32.38%
Positive BV/share change while AR is negative. John Neff sees a clear edge over a competitor losing equity.
-1.51%
We’re deleveraging while AR stands at 32.92%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.53%
SG&A declining or stable vs. AR's 41.81%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.